| (-)-N6-Phenylisopropyl adenosine |
|
|
|
|
99.45% |
| (6R)-Naxifylline |
|
|
|
|
|
| (E)-8-(3-Chlorostyryl)caffeine |
|
|
|
|
99.4% |
| (Rac)-WRC-0571 |
|
|
|
|
|
| (S)-Draflazine |
|
|
|
|
|
| (±)-5'-Chloro-5'-deoxy-ENBA |
|
|
|
|
|
| 1,9-Dimethylxanthine |
|
|
|
|
|
| 1-NBX |
|
|
|
|
|
| 2'-MeCCPA |
|
|
|
|
99.80% |
| 2,4-Dichlorothieno[3,2-d]pyrimidine |
|
|
|
|
|
| 2-Chloro-3-deazaadenosine |
|
|
|
|
|
| 2-Hexynyl-5′-N-ethylcarboxamidoadenosine |
|
|
|
|
99.39% |
| 2-Hydrazinyl-adenosine |
|
|
|
|
|
| 2-Thioadenosine |
|
|
|
|
|
| CV1808 |
|
|
|
|
98% |
| 5'-(N-Cyclopropyl)carboxamidoadenosine |
|
|
|
|
98.5% |
| 5'-N-Ethylcarboxamidoadenosine |
|
|
|
|
99.09% |
| Adenosine 5'-monophosphate disodium |
|
|
|
|
99.92% |
| 7-Methylxanthine |
|
|
|
|
99.94% |
| 7-Methyladenosine perchlorate |
|
|
|
|
|
| 8-(p-Sulfophenyl)theophylline |
|
|
|
|
≥98.0% |
| 8-Chloro caffeine |
|
|
|
|
98.52% |
| 8-Cyclopentyl-1,3-dimethylxanthine |
|
|
|
|
99.82% |
| 9-Ethyladenine |
|
|
|
|
99.79% |
| A1/A3 AR antagonist 1 |
|
|
|
|
|
| A1/A3 AR antagonist 2 |
|
|
|
|
|
| A1/A3 AR antagonist 3 |
|
|
|
|
|
| A1AR antagonist 2 |
|
|
|
|
|
| A1AR antagonist 3 |
|
|
|
|
|
| A1AR antagonist 4 |
|
|
|
|
|
| A1AR antagonist 5 |
|
|
|
|
|
| A1AR antagonist 6 |
|
|
|
|
98.13% |
| A1AR antagonist 1 |
|
|
|
|
|
| A2A receptor antagonist 1 |
|
|
|
|
98.66% |
| A2A receptor antagonist 2 |
|
|
|
|
|
| A2A receptor antagonist 3 |
|
|
|
|
99.46% |
| A2A/A1 AR antagonist-1 |
|
|
|
|
|
| A2A/A3 agonist-1 |
|
|
|
|
|
| A2A/A3 AR antagonist-1 |
|
|
|
|
|
| A2AAR antagonist 1 |
|
|
|
|
|
| A2AAR antagonist 2 |
|
|
|
|
99.40% |
| A2AAR antagonist 3 |
|
|
|
|
|
| A2AAR antagonist 4 |
|
|
|
|
|
| A2AAR antagonist 5 |
|
|
|
|
|
| A2AAR/HDAC-IN-1 |
|
|
|
|
|
| A2AAR/HDAC-IN-2 |
|
|
|
|
|
| A2AAR/hMAO-B-IN-1 |
|
|
|
|
99.0% |
| A2AR modulator-1 |
|
|
|
|
|
| A2AR-agonist-1 |
|
|
|
|
99.90% |
| A2AR-antagonist-1 |
|
|
|
|
96.68% |
| A2AR/A2BR antagonist 1 |
|
|
|
|
|
| A2AR/A2BR antagonist 2 |
|
|
|
|
|
| A2AR/EGFR-IN-1 |
|
|
|
|
|
| A2B receptor antagonist 1 |
|
|
|
|
|
| A2B receptor antagonist 2 |
|
|
|
|
99.60% |
| A3AR agonist 1 |
|
|
|
|
|
| A3AR agonist 2 |
|
|
|
|
|
| A3AR agonist 3 |
|
|
|
|
|
| A3AR agonist 4 |
|
|
|
|
|
| A3AR agonist 5 |
|
|
|
|
|
| A3AR antagonist 1 |
|
|
|
|
|
| A3AR antagonist 2 |
|
|
|
|
|
| A3AR antagonist 3 |
|
|
|
|
|
| A3AR antagonist 5 |
|
|
|
|
98.17% |
| A3AR antagonist 6 |
|
|
|
|
|
| A3AR antagonist-7 |
|
|
|
|
|
| A3AR antagonist-8 |
|
|
|
|
|
| A3AR modulator 1 |
|
|
|
|
|
| AB-MECA |
|
|
|
|
98.32% |
| ABT-702 |
|
|
|
|
99.61% |
| ABT-702 hydrochloride |
|
|
|
|
98.29% |
| Acefylline |
|
|
|
|
|
| Acefylline piperazine |
|
|
|
|
|
| Adenosine A1 receptor activator T62 |
|
|
|
|
98.93% |
| Adenosine amine congener |
|
|
|
|
98.0% |
| Adenosine antagonist-1 |
|
|
|
|
99.79% |
| Adenosine monophosphate-13C10,15N5 |
|
|
|
|
|
| Adenosine monophosphate-d12 dilithium |
|
|
|
|
95.10% |
| Adenosine receptor agonist 1 |
|
|
|
|
|
| Adenosine receptor agonist 2 |
|
|
|
|
|
| Adenosine receptor antagonist 1 |
|
|
|
|
|
| Adenosine receptor antagonist 2 |
|
|
|
|
99.37% |
| Adenosine receptor antagonist 3 |
|
|
|
|
99.12% |
| Adenosine receptor antagonist 4 |
|
|
|
|
98.09% |
| Adenosine receptor antagonist 5 |
|
|
|
|
|
| Adenosine receptor antagonist 6 |
|
|
|
|
|
| Adenosine receptor antagonist 7 |
|
|
|
|
|
| Adenosine receptor inhibitor 1 |
|
|
|
|
98.29% |
| Adenosine receptor inhibitor 2 |
|
|
|
|
99.08% |
| Adenosine-2'-monophosphate |
|
|
|
|
99.91% |
| ADORA1 modulator-1 |
|
|
|
|
|
| ADORA2A/PDE4D-IN-1 |
|
|
|
|
|
| Alloxazine |
|
|
|
|
99.46% |
| AMP-579 |
|
|
|
|
|
| Analgesic agent-4 |
|
|
|
|
|
| ANR94 |
|
|
|
|
98.91% |
| Anti-AA2AR/Adenosine A2aR Antibody (3F6-9G5) |
|
|
|
|
≥99.0% |
| Ap2A disodium |
|
|
|
|
|
| Apadenoson |
|
|
|
|
99.05% |
| APNEA |
|
|
|
|
98.96% |
| AR ligand 40 |
|
|
|
|
|
| ASP5854 |
|
|
|
|
|
| ATL-801 |
|
|
|
|
|
| ATL-802 |
|
|
|
|
|
| ATL444 |
|
|
|
|
|
| AZD9750 |
|
|
|
|
98.15% |
| Bamifylline |
|
|
|
|
|
| Bamifylline hydrochloride |
|
|
|
|
|
| BAY 60-6583 |
|
|
|
|
99.67% |
| BAY-545 |
|
|
|
|
99.79% |
| Benzo[c][1,8]naphthyridin-6(5H)-one |
|
|
|
|
|
| Binodenoson |
|
|
|
|
98.01% |
| BW-534U87 |
|
|
|
|
|
| CCD-2 |
|
|
|
|
|
| CCPA |
|
|
|
|
99.77% |
| CCPA hemihydrate |
|
|
|
|
|
| CGH2466 dihydrochloride |
|
|
|
|
|
| CGS 15943 |
|
|
|
|
99.55% |
| CGS 21680 |
|
|
|
|
99.88% |
| CGS 21680 Hydrochloride |
|
|
|
|
99.70% |
| CGS 24012 |
|
|
|
|
|
| Ciforadenant |
|
|
|
|
99.92% |
| Cirazoline hydrochloride |
|
|
|
|
99.56% |
| Cizolirtine citrate |
|
|
|
|
|
| CP-608039 |
|
|
|
|
|
| CP-66713 |
|
|
|
|
|
| CVT-2759 |
|
|
|
|
|
| CVT-2759 analog |
|
|
|
|
|
| CVT-5440 |
|
|
|
|
|
| Danshenol B |
|
|
|
|
|
| Dansyl-NECA |
|
|
|
|
|
| Derenofylline |
|
|
|
|
99.93% |
| DMPX |
|
|
|
|
99.66% |
| DPCPX |
|
|
|
|
99.96% |
| DPCPX-d4 |
|
|
|
|
|
| DPTN dihydrochloride |
|
|
|
|
98.47% |
| Draflazine |
|
|
|
|
99.06% |
| DTI 0009 |
|
|
|
|
|
| DU172 |
|
|
|
|
|
| EOS-984 |
|
|
|
|
99.98% |
| Etrumadenant |
|
|
|
|
99.67% |
| Evodenoson |
|
|
|
|
99.94% |
| FK 453 |
|
|
|
|
99.20% |
| FK 838 |
|
|
|
|
|
| FK-352 |
|
|
|
|
|
| FK3453 |
|
|
|
|
|
| FLAC6 |
|
|
|
|
|
| Flavoxate |
|
|
|
|
98.07% |
| Flavoxate-d5 |
|
|
|
|
|
| FR194921 |
|
|
|
|
98.54% |
| FSCPX |
|
|
|
|
99.72% |
| GP531 |
|
|
|
|
99.17% |
| GR79236 |
|
|
|
|
99.89% |
| GS-6201 |
|
|
|
|
98.47% |
| GS-9667 |
|
|
|
|
98.08% |
| GW 328267 |
|
|
|
|
|
| GW-493838 |
|
|
|
|
|
| hA2A/hCA XII modulator 1 |
|
|
|
|
|
| hA2AAR antagonist 1 |
|
|
|
|
|
| hA3AR agonist 1 |
|
|
|
|
|
| hA3AR agonist 2 |
|
|
|
|
|
| HEMADO |
|
|
|
|
99.0% |
| Heterobivalent ligand-1 |
|
|
|
|
|
| I-AB-MECA |
|
|
|
|
|
| IHCH-3064 |
|
|
|
|
|
| IHCH-3185 |
|
|
|
|
|
| Imaradenant |
|
|
|
|
99.52% |
| INCB106385 |
|
|
|
|
|
| Inupadenant |
|
|
|
|
98.27% |
| Inupadenant hydrochloride |
|
|
|
|
99.60% |
| IRFI-165 |
|
|
|
|
98.0% |
| ISAM-140 |
|
|
|
|
99.13% |
| JNJ-10450232 |
|
|
|
|
|
| JNJ-40255293 |
|
|
|
|
98.45% |
| KF20274 |
|
|
|
|
|
| KF21213 |
|
|
|
|
|
| KF26777 free base |
|
|
|
|
|
| KFM19 |
|
|
|
|
99.44% |
| KI-7 |
|
|
|
|
99.16% |
| KT-1 |
|
|
|
|
|
| L-97-1 |
|
|
|
|
|
| LAS101057 |
|
|
|
|
99.92% |
| LAS38096 |
|
|
|
|
|
| LASSBio-1359 |
|
|
|
|
|
| LJ-2698 |
|
|
|
|
|
| LJ-4517 |
|
|
|
|
|
| Lu AA41063 |
|
|
|
|
|
| Lu AA47070 |
|
|
|
|
|
| LUF 5608 |
|
|
|
|
|
| LUF5437 |
|
|
|
|
|
| LUF5831 |
|
|
|
|
|
| LUF5834 |
|
|
|
|
99.8% |
| LUF5981 |
|
|
|
|
|
| LUF6000 |
|
|
|
|
98.46% |
| LUF6096 |
|
|
|
|
99.16% |
| LUF7690 |
|
|
|
|
|
| M1069 |
|
|
|
|
99.52% |
| M1069 free base |
|
|
|
|
98.92% |
| MDL-102234 |
|
|
|
|
|
| MIPS3526 |
|
|
|
|
|
| MIPS521 |
|
|
|
|
98.21% |
| MK-1088 |
|
|
|
|
|
| MNI-444 |
|
|
|
|
|
| MRE 0094 |
|
|
|
|
99.73% |
| MRE3008F20 |
|
|
|
|
98.34% |
| MRS 1523 |
|
|
|
|
99.97% |
| MRS 1754 |
|
|
|
|
98.31% |
| MRS 5980 |
|
|
|
|
|
| MRS-1191 |
|
|
|
|
99.22% |
| MRS-1706 |
|
|
|
|
98.07% |
| MRS-3777 hemioxalate |
|
|
|
|
96.26% |
| MRS1067 |
|
|
|
|
|
| MRS1097 |
|
|
|
|
|
| MRS1177 |
|
|
|
|
|
| MRS1186 |
|
|
|
|
|
| MRS1220 |
|
|
|
|
99.52% |
| MRS1334 |
|
|
|
|
98.93% |
| MRS3558 |
|
|
|
|
|
| MRS542 |
|
|
|
|
|
| MRS5663 |
|
|
|
|
|
| MRS5698 |
|
|
|
|
|
| MRS7469 |
|
|
|
|
|
| MRS7799 |
|
|
|
|
|
| MRS7935 |
|
|
|
|
|
| MRS8028 |
|
|
|
|
|
| MRS8247 |
|
|
|
|
|
| MRS8454 |
|
|
|
|
|
| MSX-2 |
|
|
|
|
|
| MSX3 |
|
|
|
|
|
| N 0840 |
|
|
|
|
|
| N 0861 |
|
|
|
|
|
| N-(7H-Purin-6-yl)acetamide |
|
|
|
|
|
| N-0861 racemate |
|
|
|
|
|
| N-[(4-Aminophenyl)methyl]adenosine |
|
|
|
|
98.06% |
| N6,N6-Dimethyladenosine |
|
|
|
|
99.66% |
| N6-(2-Phenylethyl)adenosine |
|
|
|
|
99.41% |
| N6-Benzyl-5'-ethylcarboxamido adenosine |
|
|
|
|
|
| N6-Benzyladenosine |
|
|
|
|
99.72% |
| N6-Cyclohexyladenosine |
|
|
|
|
99.79% |
| N6-Cyclopentyladenosine |
|
|
|
|
99.95% |
| N6-Ethyladenosine |
|
|
|
|
99.90% |
| N6-(4-Hydroxybenzyl)adenosine |
|
|
|
|
99.84% |
| N6-Benzyladenosine-d5 |
|
|
|
|
|
| Namodenoson |
|
|
|
|
99.56% |
| Naxifylline |
|
|
|
|
|
| NBUMP |
|
|
|
|
|
| Neladenoson |
|
|
|
|
99.95% |
| Neladenoson dalanate |
|
|
|
|
|
| Neladenoson dalanate hydrochloride |
|
|
|
|
|
| Nitrobenzylthioinosine |
|
|
|
|
98.57% |
| NPC 200 |
|
|
|
|
|
| OT-7100 |
|
|
|
|
|
| p-Iodoclonidine hydrochloride |
|
|
|
|
99.61% |
| PBF-999 |
|
|
|
|
98.89% |
| PD 117519 |
|
|
|
|
99.97% |
| PD81723 |
|
|
|
|
99.63% |
| Piclidenoson |
|
|
|
|
99.01% |
| PPAR agonist 7 |
|
|
|
|
|
| PQ-69 |
|
|
|
|
|
| Propentofylline |
|
|
|
|
99.88% |
| Propentofylline-d6 |
|
|
|
|
|
| PSB 0777 ammonium |
|
|
|
|
|
| PSB 0777 ammonium hydrate |
|
|
|
|
99.68% |
| PSB-0788 |
|
|
|
|
99.68% |
| PSB-10 hydrochloride |
|
|
|
|
|
| PSB-1115 |
|
|
|
|
99.09% |
| PSB-1115 potassium salt |
|
|
|
|
|
| PSB-1901 |
|
|
|
|
96.33% |
| PSB-603 |
|
|
|
|
99.38% |
| PSB11 hydrochloride |
|
|
|
|
|
| PSB36 |
|
|
|
|
99.13% |
| Regadenoson hydrate |
|
|
|
|
|
| Rolofylline |
|
|
|
|
99.68% |
| SCH 58261 |
|
|
|
|
99.71% |
| SCH-202676 |
|
|
|
|
99.46% |
| SCH-202676 hydrobromide |
|
|
|
|
98.85% |
| Sch412348 |
|
|
|
|
|
| SCH442416 |
|
|
|
|
99.94% |
| SDZ-WAG994 |
|
|
|
|
|
| Sipagladenant |
|
|
|
|
99.68% |
| ST 1535 |
|
|
|
|
|
| ST3932 |
|
|
|
|
|
| ST4206 |
|
|
|
|
|
| Sulcatone |
|
|
|
|
98.63% |
| Sulcatone-d5 |
|
|
|
|
|
| SYAF080 |
|
|
|
|
|
| Taminadenant |
|
|
|
|
99.84% |
| Taminadenant mesylate |
|
|
|
|
|
| TAT-GluA2 3Y |
|
|
|
|
99.93% |
| TC-G 1004 |
|
|
|
|
98.11% |
| Tecadenoson |
|
|
|
|
99.69% |
| Theobromine |
|
|
|
|
99.55% |
| Theobromine-d3 |
|
|
|
|
99.78% |
| Theophylline L-lysine |
|
|
|
|
|
| Tonapofylline |
|
|
|
|
98.99% |
| Tozadenant |
|
|
|
|
99.17% |
| Trabodenoson |
|
|
|
|
99.97% |
| TRR469 |
|
|
|
|
|
| UK-432097 |
|
|
|
|
98.9% |
| UP202-56 |
|
|
|
|
|
| VCP171 |
|
|
|
|
99.18% |
| Vipadenant |
|
|
|
|
98.02% |
| VUF-5574 |
|
|
|
|
99.0% |
| VUF8504 |
|
|
|
|
|
| VUF8507 |
|
|
|
|
|
| Xanthine amine congener |
|
|
|
|
|
| Xanthine amine congener dihydrochloride |
|
|
|
|
|
| Xanthine amine congener hydrochloride |
|
|
|
|
98.03% |
| Xanthine amine congener trihydrochloride |
|
|
|
|
|
| XCC |
|
|
|
|
|
| YGZ-331 |
|
|
|
|
|
| YT 146 |
|
|
|
|
99.72% |
| Zaladenant |
|
|
|
|
|
| ZM241385 |
|
|
|
|
99.45% |
| ZM241385-d7 |
|
|
|
|
|
| Theophylline sodium acetate |
|
|
|
|
|
| Diphylline |
|
|
|
|
99.22% |
| Istradefylline |
|
|
|
|
99.89% |
| Istradefylline-13C,d3 |
|
|
|
|
98.27% |
| A3AR antagonist 4 |
|
|
|
|
99.98% |
| Capadenoson |
|
|
|
|
98.43% |
| Theobromine-d6 |
|
|
|
|
98.0% |
| Doxofylline |
|
|
|
|
99.97% |
| Doxofylline-d4 |
|
|
|
|
|
| Doxofylline-d6 |
|
|
|
|
99.61% |
| Pamabrom |
|
|
|
|
99.92% |
| Adenosine 5'-monophosphate monohydrate |
|
|
|
|
99.81% |
| Swertisin |
|
|
|
|
99.54% |
| Enprofylline |
|
|
|
|
98.71% |
| Norisoboldine hydrochloride |
|
|
|
|
99.87% |
| Norisoboldine |
|
|
|
|
99.93% |
| Aminophylline |
|
|
|
|
99.68% |
| Regadenoson-d3 |
|
|
|
|
|
| Regadenoson |
|
|
|
|
98.83% |
| Preladenant |
|
|
|
|
99.82% |
| Flavoxate hydrochloride |
|
|
|
|
99.70% |
| Flavoxate-d4 hydrochloride |
|
|
|
|
|
| (Rac)-Mirabegron-d5 |
|
|
|
|
|
| Proxyphylline |
|
|
|
|
99.93% |
| Inosine |
|
|
|
|
99.94% |
| Inosine-2,8-d2 |
|
|
|
|
99.69% |
| Inosine-13C3 |
|
|
|
|
|
| Inosine-13C5 |
|
|
|
|
99.90% |
| Inosine-13C |
|
|
|
|
|
| Adenosine monophosphate-13C10,15N5 dilithium |
|
|
|
|
99.9% |
| Adenosine monophosphate-15N5 dilithium |
|
|
|
|
99.22% |
| Adenosine monophosphate |
|
|
|
|
99.80% |
| Adenosine monophosphate-13C10,15N5,d12 dilithium |
|
|
|
|
|
| Adenosine monophosphate-13C10 dilithium |
|
|
|
|
99.2% |
| Adenosine monophosphate-15N5,d12 dilithium |
|
|
|
|
99.50% |
| Sulmazole |
|
|
|
|
|
| Theophylline |
|
|
|
|
99.97% |
| Theophylline-d6 |
|
|
|
|
99.30% |
| Theophylline-13C2,d6 |
|
|
|
|
|
| Theophylline-d3 |
|
|
|
|
|
| Acefylline |
|
|
|
|
99.52% |
| Theophylline monohydrate |
|
|
|
|
99.93% |
| Theophylline (sodium glycinate) |
|
|
|
|
|